| Strategies to improve antimicrobial utilization with a special focus on developing countries B Godman, A Egwuenu, M Haque, OO Malande, N Schellack, S Kumar, ... Life 11 (6), 528, 2021 | 210 | 2021 |
| Emergence of trimethoprim resistance gene dfrG in Staphylococcus aureus causing human infection and colonization in sub-Saharan Africa and its import to Europe D Nurjadi, AO Olalekan, F Layer, AO Shittu, A Alabi, B Ghebremedhin, ... Journal of Antimicrobial Chemotherapy 69 (9), 2361-2368, 2014 | 121 | 2014 |
| Key issues surrounding appropriate antibiotic use for prevention of surgical site infections in low-and middle-income countries: a narrative review and the implications JC Mwita, OO Ogunleye, A Olalekan, AC Kalungia, A Kurdi, Z Saleem, ... International journal of general medicine, 515-530, 2021 | 77 | 2021 |
| Clonal expansion accounts for an excess of antimicrobial resistance in Staphylococcus aureus colonising HIV-positive individuals in Lagos, Nigeria AO Olalekan, F Schaumburg, D Nurjadi, AE Dike, O Ojurongbe, ... International journal of antimicrobial agents 40 (3), 268-272, 2012 | 47 | 2012 |
| High proportion of carbapenemase-producing Escherichia coli and Klebsiella pneumoniae among extended-spectrum β-lactamase-producers in Nigerian hospitals A Olalekan, F Onwugamba, B Iwalokun, A Mellmann, K Becker, ... Journal of global antimicrobial resistance 21, 8-12, 2020 | 44 | 2020 |
| Landscape of tobacco control in sub-Saharan Africa CO Egbe, P Magati, E Wanyonyi, L Sessou, E Owusu-Dabo, ... Tobacco Control 31 (2), 153-159, 2022 | 41 | 2022 |
| COVID-19 rapid diagnostic test could contain transmission in low-and middle-income countries A Olalekan, B Iwalokun, OM Akinloye, O Popoola, TA Samuel, O Akinloye African Journal of Laboratory Medicine 9 (1), 1-8, 2020 | 37 | 2020 |
| A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: Findings and … OO Ogunleye, MR Oyawole, PT Odunuga, F Kalejaye, ... Expert review of anti-infective therapy 20 (2), 297-306, 2022 | 33 | 2022 |
| High incidence of carbapenemase-producing Pseudomonas aeruginosa clinical isolates from Lagos, Nigeria A Olalekan, BK Bader, B Iwalokun, S Wolf, A Lalremruata, A Dike, ... JAC-Antimicrobial Resistance 5 (2), dlad038, 2023 | 9 | 2023 |
| Persistent Staphylococcus aureus nasal colonization in ambulatory human immunodeficiency virus-infected patients in Nigeria: Risk factors and molecular features AO Olalekan, SS Taiwo, SI Smith, AO Shittu, DO Kolawole, F Schaumburg Journal of Microbiology, Immunology and Infection 49 (6), 992-995, 2016 | 7 | 2016 |
| Improving the understanding of the immunopathogenesis of lymphopenia as a correlate of SARS-CoV-2 infection risk and disease progression in African patients: protocol for a … BA Iwalokun, A Olalekan, E Adenipekun, O Ojo, SO Iwalokun, B Mutiu, ... JMIR Research Protocols 10 (3), e21242, 2021 | 6 | 2021 |
| Case Report on Pleural Empyema Thoracis and Urinary Tract Infection Caused by Chromobacterium violaceum from Lagos, Nigeria A Olalekan, F Itua, B Mutiu, T Egwuatu, O Akinloye, B Iwalokun Case Reports in Medicine 2019 (1), 5321484, 2019 | 6 | 2019 |
| Chloroquine resistance molecular markers in Falciparum malaria in Edo State M Tatfeng, A Youtchou, E Dennis, AO Olalekan, ... The Japanese Society of Tropical Medicine and Health 37 (2), 37- 41, 2009 | 2 | 2009 |
| Assessment of pre-eclampsia and eclampsia health commodities’ supply chains in selected hospitals of Lagos State during COVID-19 pandemic A Olalekan, V Igweike, O Ekun, A Adegbite, O Ogunleye Journal of Humanitarian Logistics and Supply Chain Management 14 (1), 71-81, 2024 | 1 | 2024 |
| Performance assessment of SD Bioline TB MPT64 assay for the diagnosis of Mycobacterium tuberculosis complex in Lagos, Nigeria TY Raheem, O Ojo, EO Adenipekun, AO Olalekan, A Oluwadun, ... Journal of Immunoassay and Immunochemistry 42 (5), 543-558, 2021 | 1 | 2021 |
| 'Understanding the use of real time reverse trascriptase polymerase chain reaction (Rrt-PCR) for COVID 19 Diagnosis2 A Olalekan, B Iwalokun, O Adekunle, H Makun, T Mirabeau, O Akinloye Pan African Journal of Life Sciences, 2020 | 1 | 2020 |
| Phylogroup profiling and the genetic determinants of extended spectrum beta-lactamase producing Escherichia coli isolated from clinical samples in lagos, Nigeria AO Olalekan, F Onwugamba, B Iwalokun Ife Journal of Science 22 (3), 159-166, 2020 | 1 | 2020 |
| Haematological and haemostatic changes in adults on substance abuse in Lagos metropolis Nigeria OA Ekun, OA Adebayo, OT Okunola, AO Olalekan, NO Ogidi Nigerian Quarterly Journal of Hospital Medicine 29 (1-2), 73-80, 2019 | 1 | 2019 |
| Fortitude in the face of crisis: Unraveling the nexus of grit, motivation, and self-esteem among health workers in COVID-19 treatment and diagnostic centres in Nigeria … M Aguwa, A Olalekan, T Ojurongbe, S Busari-Akinbode, A Adegbite, ... Babcock University Medical Journal 7 (1), 107-116, 2024 | | 2024 |
| Antimicrobial Susceptibility Profile and Frequency of ESBL Gene Determinants among Klebsiella pneumoniae Isolates from Patients attending an Urban Secondary Health Facility in … AO Olalekan, A Babalola, OO Ogunleye, B Opere, OA Ekun, IO Ajani, ... University of Lagos Journal of Basic Medical Sciences 9 (1-2), 2022 | | 2022 |
Bamidele IwalokunDirector of Central Research Laboratory, Nigerian Institute of Medical Research.E-mail megerősítve itt: nimr.gov.ng